2024
W80 Buprenorphine-Naloxone vs. Extended-Release Naltrexone for Opioid Use Disorder in People With Recent Criminal Legal Involvement: A Secondary Analysis of the X:BOT Randomized Controlled Trial
Balter D, Puglisi L, Dziura J, Fiellin D, Howell B. W80 Buprenorphine-Naloxone vs. Extended-Release Naltrexone for Opioid Use Disorder in People With Recent Criminal Legal Involvement: A Secondary Analysis of the X:BOT Randomized Controlled Trial. Drug And Alcohol Dependence 2024, 260: 110698. DOI: 10.1016/j.drugalcdep.2023.110698.Peer-Reviewed Original ResearchBuprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial
Balter D, Puglisi L, Dziura J, Fiellin D, Howell B. Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial. Journal Of Substance Use And Addiction Treatment 2024, 164: 209438. PMID: 38857827, PMCID: PMC11300157, DOI: 10.1016/j.josat.2024.209438.Peer-Reviewed Original ResearchXR-NTXBuprenorphine-naloxoneOpioid use disorderCriminal legal involvementUse disorderHazard of overdoseLifetime incarcerationLegal involvementOpioid use disorder treatment outcomesPer-protocol analysisExtended-release naltrexoneMOUD effectivenessTreatment outcomesEffects of medicationHazard of relapseSecondary analysisIntention-to-treat analysisIntention-to-treatRandomized controlled trialsEffects of MOUDRelapseControlled trialsDisordersOpioidPotential effect modifiers
2021
The Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use disorder treatment outcomes following release from jail
Howell BA, Puglisi L, Clark K, Albizu-Garcia C, Ashkin E, Booth T, Brinkley-Rubinstein L, Fiellin DA, Fox AD, Maurer KF, Lin HJ, McCollister K, Murphy S, Morse DS, Shavit S, Wang K, Winkelman T, Wang EA. The Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support (TCN-PATHS): A hybrid type-1 effectiveness trial of enhanced primary care to improve opioid use disorder treatment outcomes following release from jail. Journal Of Substance Use And Addiction Treatment 2021, 128: 108315. PMID: 33583610, PMCID: PMC8319218, DOI: 10.1016/j.jsat.2021.108315.Peer-Reviewed Original ResearchConceptsTransitions Clinic NetworkOpioid use disorderPrimary careTreatment cascadeClinic networkOpioid Use Disorder Treatment OutcomesMedical needData Safety Monitoring BoardStandard primary careCommunity health centersCommunity health workersPrimary care teamsSafety monitoring boardCause of deathDisorder treatment outcomesPatient's medical needsHistory of incarcerationPolicy-level barriersOUD treatmentCare teamEffectiveness trialHealth centersTreatment outcomesCommon causeOpioid overdose
2019
Medications for Opioid Use Disorder Among Incarcerated Individuals: a Review of the Literature and Focus on Patient Preference
Puglisi L, Bedell P, Steiner A, Wang E. Medications for Opioid Use Disorder Among Incarcerated Individuals: a Review of the Literature and Focus on Patient Preference. Current Addiction Reports 2019, 6: 365-373. DOI: 10.1007/s40429-019-00283-x.Peer-Reviewed Original ResearchPatient preferencesMOUD treatmentUse disordersEffectiveness studiesOpioid use disorderChronic health conditionsNeed-based factorsPatient-centered researchCommon diagnosisPatients' perceptionsTreatment utilizationTreatment decisionsMOUDTreatment engagementIncarcerated peopleHealth needsMedicationsStudy designHealth conditionsVulnerable populationsTreatmentDisordersIncarcerated individualsFuture studiesCorrectional populations